APA citiranje

Lin, T. S., Ruppert, A. S., Johnson, A. J., Fischer, B., Heerema, N. A., Andritsos, L. A., . . . Byrd, J. C. (2009). Phase II Study of Flavopiridol in Relapsed Chronic Lymphocytic Leukemia Demonstrating High Response Rates in Genetically High-Risk Disease. American Society of Clinical Oncology.

Citação norma Chicago

Lin, Thomas S., et al. Phase II Study of Flavopiridol in Relapsed Chronic Lymphocytic Leukemia Demonstrating High Response Rates in Genetically High-Risk Disease. American Society of Clinical Oncology, 2009.

MLA citiranje

Lin, Thomas S., et al. Phase II Study of Flavopiridol in Relapsed Chronic Lymphocytic Leukemia Demonstrating High Response Rates in Genetically High-Risk Disease. American Society of Clinical Oncology, 2009.